TritonPoint Wealth’s AbbVie ABBV Stock Holding History

TritonPoint Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.75M	Buy	10,518 +15	+0.1%	+$3.84K	0.27%	83
2026 Q2	$2.64M	Sell	10,503 -873	-8%	-$188K	0.26%	86
2026 Q1	$2.47M	Sell	11,376 -722	-6%	-$160K	0.26%	83
2025 Q4	$2.76M	Sell	12,098 -538	-4%	-$123K	0.28%	83
2025 Q3	$2.93M	Buy	12,636 +220	+2%	+$44.8K	0.25%	97
2025 Q2	$2.3M	Buy	12,416 +213	+2%	+$39.6K	0.21%	108
2025 Q1	$2.56M	Buy	12,203 +830	+7%	+$161K	0.24%	95
2024 Q4	$2.02M	Buy	11,373 +633	+6%	+$116K	0.18%	116
2024 Q3	$2.09M	Buy	10,740 +697	+7%	+$130K	0.19%	113
2024 Q2	$1.72M	Sell	10,043 -1,787	-15%	-$296K	0.17%	118
2024 Q1	$1.75M	Sell	11,830 -1,134	-9%	-$195K	0.18%	114
2023 Q4	$2.01M	Buy	+12,964	New	+$1.89M	0.2%	111

Other funds holding ABBV

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Bahl & Gaynor Cincinnati, Ohio $21B AUM 23.02% 1-Year Est. Return

TritonPoint Wealth's ABBV Position: Q3 2026 in Review

TritonPoint Wealth increased its AbbVie (ABBV) stake by 0.14% in Q3 2026, buying an estimated $3.84K and bringing the position to 10,518 shares worth $2.75M. The position accounts for 0.27% of the portfolio, ranked #83.

TritonPoint Wealth first reported a position in ABBV in Q4 2023 and has held it in 12 quarters since. The position peaked at $2.93M in Q3 2025. 2,620 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

TritonPoint Wealth held 10,518 shares of AbbVie worth $2.75M as of Q3 2026.
TritonPoint Wealth bought 15 AbbVie shares in Q3 2026, an estimated $3.84K.
AbbVie made up 0.27% of TritonPoint Wealth's portfolio in Q3 2026, its #83 holding.
TritonPoint Wealth first reported a position in AbbVie in Q4 2023 and has held it in 12 quarters since.
TritonPoint Wealth's AbbVie position peaked at $2.93M in Q3 2025.
2,620 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on TritonPoint Wealth's 13F filing for Q3 2026, filed 19 Oct 2026.